The Companies and Markets ShowBitcoin’s new boost, Volution, CVSJulian Hofmann leads the discussion on a little-known FTSE 100 business, a US healthcare company and a change in cryptocurrency rules10 October 2025Save
EconomicsToday’s markets: FTSE flirts with another highUpdates on world markets and companies news3 October 2025Save
The Companies and Markets ShowHow to pass on wealth, AstraZeneca & CeresDan Jones and co unpack why shares in the UK pharma giant shot up, how to effectively pass on wealth and results from a clean power generator3 October 2025Save
The Companies and Markets ShowTrustpilot, the North Sea & GoodwinDan Jones and co unpack results from a leading reviews platform, North Sea oil polices and a trading update from an engineering business26 September 2025Save
The Companies and Markets ShowTop 50 Funds, GSK & MondiDan Jones and co unpack our annual Top 50 Funds feature, and two companies from our Income Majors Special Report19 September 2025Save
The Companies and Markets ShowAnglo Teck deal, Property Franchise Group & WickesDan Jones and our panel of journalists dive into a copper mining megamerger, and results from an estate agency franchising group and a well-known DIY business12 September 2025Save
The Companies and Markets ShowHow European markets are faring, investment clubs & UnipharDan Jones and our panel of journalists unpack the positive and negative developments in Europe, the future of investment clubs and a pharmaceutical manufacturer’s results5 September 2025Save
The Companies and Markets ShowNvidia, nuclear’s revival & BoohooDan Jones and the team delve into the nuclear energy market, and results from the biggest name in tech and a British clothing retailer29 August 2025Save
The Companies and Markets ShowPensionBee, Applied Nutrition & leasehold issuesOur team dives into the results from two recently listed UK companies and investing in leasehold properties22 August 2025Save
The Companies and Markets ShowSpotting undervalued shares, Savills & weight-loss drugsAs results season winds down, Dan Jones and team discuss a property group’s results, alternative ways to find bargain stocks and Novo Nordisk vs Eli Lilly15 August 2025Save